Call for new treatments after first major study into rare, painful and disfiguring skin condition
From Elizabeth Cass
Pyoderma gangrenosum (PG) affects less than 400 people each year but it can be so severe in some cases it has led to amputation. The condition is so rare it is often misdiagnosed. The NIHR-funded STOP GAP trial – the Study of Treatments for Pyoderma Gangrenosum Patients – was developed by Professor Kim Thomas and Professor Hywel Williams, Co-Directors of the Centre of Evidence Based Dermatology based at The University of Nottingham, and Anthony Ormerod, Professor of Dermatology and John Norrie, Professor Clinical Trials and Biostatistics at Aberdeen University. The randomised controlled trial was managed by the Nottingham Clinical Trials Unit and sponsored by Nottingham University Hospitals NHS Trust.